316 related articles for article (PubMed ID: 37799731)
1. APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder.
Sokol DK; Lahiri DK
Front Mol Neurosci; 2023; 16():1201744. PubMed ID: 37799731
[TBL] [Abstract][Full Text] [Related]
2. Finding novel distinctions between the sAPPα-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue.
Ray B; Sokol DK; Maloney B; Lahiri DK
Sci Rep; 2016 May; 6():26052. PubMed ID: 27212113
[TBL] [Abstract][Full Text] [Related]
3. Novel Contribution of Secreted Amyloid-β Precursor Protein to White Matter Brain Enlargement in Autism Spectrum Disorder.
Sokol DK; Maloney B; Westmark CJ; Lahiri DK
Front Psychiatry; 2019; 10():165. PubMed ID: 31024350
[TBL] [Abstract][Full Text] [Related]
4. Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.
Erickson CA; Ray B; Maloney B; Wink LK; Bowers K; Schaefer TL; McDougle CJ; Sokol DK; Lahiri DK
J Psychiatr Res; 2014 Dec; 59():220-8. PubMed ID: 25300441
[TBL] [Abstract][Full Text] [Related]
5. Pten Mutations Alter Brain Growth Trajectory and Allocation of Cell Types through Elevated β-Catenin Signaling.
Chen Y; Huang WC; Séjourné J; Clipperton-Allen AE; Page DT
J Neurosci; 2015 Jul; 35(28):10252-67. PubMed ID: 26180201
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.
Westmark CJ; Sokol DK; Maloney B; Lahiri DK
Mol Psychiatry; 2016 Oct; 21(10):1333-41. PubMed ID: 27573877
[TBL] [Abstract][Full Text] [Related]
7. Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway.
Lahiri DK; Sokol DK; Erickson C; Ray B; Ho CY; Maloney B
Front Cell Neurosci; 2013; 7():94. PubMed ID: 23801940
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.
Yeung KS; Tso WWY; Ip JJK; Mak CCY; Leung GKC; Tsang MHY; Ying D; Pei SLC; Lee SL; Yang W; Chung BH
Mol Autism; 2017; 8():66. PubMed ID: 29296277
[TBL] [Abstract][Full Text] [Related]
9. Pten haploinsufficient mice show broad brain overgrowth but selective impairments in autism-relevant behavioral tests.
Clipperton-Allen AE; Page DT
Hum Mol Genet; 2014 Jul; 23(13):3490-505. PubMed ID: 24497577
[TBL] [Abstract][Full Text] [Related]
10. PTEN Regulates Dendritic Arborization by Decreasing Microtubule Polymerization Rate.
Getz SA; Tariq K; Marchand DH; Dickson CR; Howe Vi JR; Skelton PD; Wang W; Li M; Barry JM; Hong J; Luikart BW
J Neurosci; 2022 Mar; 42(10):1945-1957. PubMed ID: 35101965
[TBL] [Abstract][Full Text] [Related]
11. mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.
Thomas SD; Jha NK; Ojha S; Sadek B
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838876
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
13. Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypes.
Zhang W; Ma L; Yang M; Shao Q; Xu J; Lu Z; Zhao Z; Chen R; Chai Y; Chen JF
Genes Dev; 2020 Apr; 34(7-8):580-597. PubMed ID: 32115408
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly.
Sokol DK; Lahiri DK
Front Mol Neurosci; 2023; 16():1201723. PubMed ID: 37808474
[TBL] [Abstract][Full Text] [Related]
15. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.
Sokol DK; Maloney B; Long JM; Ray B; Lahiri DK
Neurology; 2011 Apr; 76(15):1344-52. PubMed ID: 21482951
[TBL] [Abstract][Full Text] [Related]
16. Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorder.
Prohl AK; Scherrer B; Tomas-Fernandez X; Davis PE; Filip-Dhima R; Prabhu SP; Peters JM; Bebin EM; Krueger DA; Northrup H; Wu JY; Sahin M; Warfield SK;
J Neurodev Disord; 2019 Dec; 11(1):36. PubMed ID: 31838998
[TBL] [Abstract][Full Text] [Related]
17. Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening.
Marchese M; Conti V; Valvo G; Moro F; Muratori F; Tancredi R; Santorelli FM; Guerrini R; Sicca F
BMC Med Genet; 2014 Feb; 15():26. PubMed ID: 24580998
[TBL] [Abstract][Full Text] [Related]
18. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression.
Sokol DK; Chen D; Farlow MR; Dunn DW; Maloney B; Zimmer JA; Lahiri DK
J Child Neurol; 2006 Jun; 21(6):444-9. PubMed ID: 16948926
[TBL] [Abstract][Full Text] [Related]
19. Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase.
Shineman DW; Dain AS; Kim ML; Lee VM
Biochemistry; 2009 May; 48(17):3787-94. PubMed ID: 19236051
[TBL] [Abstract][Full Text] [Related]
20. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker.
Ray B; Long JM; Sokol DK; Lahiri DK
PLoS One; 2011; 6(6):e20405. PubMed ID: 21731612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
